Kidney care advocates urge passage of key legislation for Georgia’s kidney patients

NewsGuard 100/100 Score

On Tuesday, February 9, kidney patients from across the state of Georgia will join Dialysis Patient Citizens (DPC) – a national, non-profit, patient-led organization representing approximately 1,300 members in Georgia and 22,000 members nationwide – in holding a briefing at the State Capitol, followed by a series of meetings with lawmakers and staff, urging the passage of key legislation this year that would help thousands of Georgia’s kidney failure patients who are struggling to access health insurance for the medical care they need.

The legislation – S.B. 316, sponsored by State Senators Don Thomas (R-Dalton) and Ed Harbison (D-Columbus) – would provide the opportunity for approximately 2,000 Georgia end stage renal disease (ESRD) patients and disabled patients under the age of 65 to access Medigap secondary coverage. Under current federal law, all Medicare beneficiaries over the age of 65 are already able to purchase Medigap, which provides them with access to needed medical treatments, including kidney transplant, without cost being a barrier. Patients and kidney care advocates will ask lawmakers to extend the same coverage to Georgia’s ESRD and disabled Medicare beneficiaries under age 65.

If Georgia passes this important legislation, fewer people will be forced to “spend down” their assets to enter the state Medicaid program, resulting in Medicaid savings of up to $20 million over the next five years for Georgia and protecting taxpayers from higher program costs.

Come meet patients and learn about their experiences with kidney disease, and find out why this legislation is good for patients, good for taxpayers and good for Georgia.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New model predicts kidney injury risk in cancer patients on cisplatin